$DVAX DYNAVAX TECHNOLOGIES CORP Insider Trading
Get free email notifications about insider trading in DYNAVAX TECHNOLOGIES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DYNAVAX TECHNOLOGIES CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in DYNAVAX TECHNOLOGIES CORP for free.
CIK Number: 0001029142
IRS Number: 330728374
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: DVAX
Company Address: 2100 POWELL STREET SUITE 900 EMERYVILLE 94608
Phone number: 5108485100
Market Capitalization: $154.11M
Prev close: $3.95
Average Daily Volume: 1,900,690
Days Low: $3.80
Year Low: $3.20
Year High: $23.62
DYNAVAX TECHNOLOGIES CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | DVAX | DYNAVAX TECHNOLOGI ... | MacGregor Brent | Director | Option Exercise | A | 8.20 | 25,000 | 205,000 | 25,000 | |
Jun 02 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Hack Andrew A. F. | Director | Option Exercise | A | 8.20 | 25,000 | 205,000 | 25,000 | |
Apr 02 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Novack David F | President & COO | Sell | S | 9.92 | 20,000 | 198,400 | 117,399 | 137.4 K to 117.4 K (-14.56 %) |
Apr 02 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Novack David F | President & COO | Grant | A | 3.39 | 2,500 | 8,475 | 137,399 | 134.9 K to 137.4 K (+1.85 %) |
Mar 12 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Janssen Robert | Senior Vice Preside ... | Gift | G | 0.00 | 1,000 | 0 | 86,861 | 87.9 K to 86.9 K (-1.14 %) |
Feb 23 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Spencer Ryan | CEO and Director | Option Exercise | M | 0.00 | 20,833 | 0 | 20,833 | |
Feb 23 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Spencer Ryan | CEO and Director | Payment of Exercise | F | 9.60 | 10,791 | 103,594 | 69,620 | 80.4 K to 69.6 K (-13.42 %) |
Feb 23 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Spencer Ryan | CEO and Director | Buy | M | 0.00 | 20,833 | 0 | 80,411 | 59.6 K to 80.4 K (+34.97 %) |
Feb 23 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Spencer Ryan | CEO and Director | Grant | A | 3.39 | 1,519 | 5,149 | 59,578 | 58.1 K to 59.6 K (+2.62 %) |
Feb 05 2021 | DVAX | DYNAVAX TECHNOLOGI ... | OSTRACH MICHAEL S | Senior Vice Preside ... | Option Exercise | A | 9.41 | 85,000 | 799,850 | 85,000 | |
Feb 05 2021 | DVAX | DYNAVAX TECHNOLOGI ... | OSTRACH MICHAEL S | Senior Vice Preside ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 05 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Spencer Ryan | CEO and Director | Option Exercise | A | 9.59 | 250,000 | 2,397,500 | 250,000 | |
Feb 05 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Spencer Ryan | CEO and Director | Option Exercise | A | 0.00 | 89,250 | 0 | 89,250 | |
Feb 05 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Spencer Ryan | CEO and Director | Grant | A | 3.39 | 1,518 | 5,146 | 58,059 | 56.5 K to 58.1 K (+2.68 %) |
Feb 05 2021 | DVAX | DYNAVAX TECHNOLOGI ... | Novack David F | President & COO | Option Exercise | A | 9.41 | 150,000 | 1,411,500 | 150,000 |